343 related articles for article (PubMed ID: 3476201)
1. Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia.
Paciucci PA; Keaveney C; Cuttner J; Holland JF
Cancer Res; 1987 Oct; 47(19):5234-7. PubMed ID: 3476201
[TBL] [Abstract][Full Text] [Related]
2. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
Paciucci PA; Cuttner J; Holland JF
Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
[TBL] [Abstract][Full Text] [Related]
3. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
Sampi K; Ogawa M; Kimura I; Ohnoshi T; Yamada K; Masaoka T; Wakui A; Meguro S; Nagai K; Kitani T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3021-7. PubMed ID: 3464230
[TBL] [Abstract][Full Text] [Related]
4. Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia: a co-operative study.
Marks SM; Baltimore D; McCaffrey R
N Engl J Med; 1978 Apr; 298(15):812-4. PubMed ID: 273142
[TBL] [Abstract][Full Text] [Related]
5. A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia.
Bassan R; Lerede T; Buelli M; Borleri G; Bellavita P; Rambaldi A; Barbui T
Haematologica; 1998 May; 83(5):422-7. PubMed ID: 9658726
[TBL] [Abstract][Full Text] [Related]
6. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J
Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387
[TBL] [Abstract][Full Text] [Related]
7. Use of terminal deoxynucleotidyl transferase in the diagnosis of leukemia.
Morse EE; Gaffney J; Donskoy E; Pisciotto P; Altman A; Quinn J; Goldschneider I
Ann Clin Lab Sci; 1983; 13(2):128-32. PubMed ID: 6344744
[TBL] [Abstract][Full Text] [Related]
8. Intensive chemotherapy with mitoxantrone administered as a single injection in patients with high-risk acute myeloid leukemia: results of the EMA 2000 trial.
Thomas X; Elhamri M; Chelghoum Y; Reman O; Arnaud P; Raffoux E; Le QH; Tavernier E; Dombret H; Michallet M
Ann Hematol; 2005 Jun; 84(6):376-82. PubMed ID: 15782343
[TBL] [Abstract][Full Text] [Related]
9. Combination of 6-mercaptopurine, vincristine, methotrexate, and prednisone in resistant or relapsed acute nonlymphoid leukemia.
Leone G; Pagano L; Marra R; Landolfi R; Cudillo L; Storti S; Mango G; Alfano G; D'Onofrio G
Cancer Treat Rep; 1987; 71(7-8):751-3. PubMed ID: 3607785
[TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
[TBL] [Abstract][Full Text] [Related]
12. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of leukemia cell terminal transferase measurements.
McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
[TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study.
Tallman MS; Lee S; Sikic BI; Paietta E; Wiernik PH; Bennett JM; Rowe JM
Cancer; 1999 Jan; 85(2):358-67. PubMed ID: 10023703
[TBL] [Abstract][Full Text] [Related]
15. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
[TBL] [Abstract][Full Text] [Related]
16. Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG).
Giebel S; Krawczyk-Kulis M; Adamczyk-Cioch M; Jakubas B; Palynyczko G; Lewandowski K; Dmoszynska A; Skotnicki A; Nowak K; Holowiecki J;
Ann Hematol; 2006 Oct; 85(10):717-22. PubMed ID: 16832677
[TBL] [Abstract][Full Text] [Related]
17. Phase I-II trial of mitoxantrone in acute leukemia.
Arlin ZA; Silver R; Cassileth P; Armentrout S; Gams R; Daghestani A; Coleman M; Schoch I; Dukart G
Cancer Treat Rep; 1985 Jan; 69(1):61-4. PubMed ID: 3855386
[TBL] [Abstract][Full Text] [Related]
18. Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
Clavio M; Venturino C; Pierri I; Garrone A; Miglino M; Canepa L; Balleari E; Balocco M; Michelis GL; Ballerini F; Gobbi M
Ann Hematol; 2004 Nov; 83(11):696-703. PubMed ID: 15322763
[TBL] [Abstract][Full Text] [Related]
19. Mitoxantrone and ara-C in previously treated patients with acute myelogenous leukemia.
Paciucci PA; Dutcher JP; Cuttner J; Strauman JJ; Wiernik PH; Holland JF
Leukemia; 1987 Jul; 1(7):565-7. PubMed ID: 3478540
[TBL] [Abstract][Full Text] [Related]
20. [A case of Ph1-positive chronic myeloid leukemia blast crisis with a high level of terminal deoxynucleotidyl transferase responded to vincristine and prednisolone therapy (author's transl)].
Nagai K; Nesumi N; Higashida M; Nagata I; Ueshima Y; Sawada H; Uchino H
Rinsho Ketsueki; 1979 Sep; 20(9):1154-61. PubMed ID: 292803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
